Cargando…
Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes
Modifications like asparagine deamidation, aspartate isomerization, methionine oxidation, and lysine glycation are typical degradations for recombinant antibodies. For the identification and functional evaluation of antibody critical quality attributes (CQAs) derived from chemical modifications in t...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984323/ https://www.ncbi.nlm.nih.gov/pubmed/24441081 http://dx.doi.org/10.4161/mabs.27876 |
_version_ | 1782311441221550080 |
---|---|
author | Haberger, Markus Bomans, Katrin Diepold, Katharina Hook, Michaela Gassner, Jana Schlothauer, Tilman Zwick, Adrian Spick, Christian Kepert, Jochen Felix Hienz, Brigitte Wiedmann, Michael Beck, Hermann Metzger, Philipp Mølhøj, Michael Knoblich, Constanze Grauschopf, Ulla Reusch, Dietmar Bulau, Patrick |
author_facet | Haberger, Markus Bomans, Katrin Diepold, Katharina Hook, Michaela Gassner, Jana Schlothauer, Tilman Zwick, Adrian Spick, Christian Kepert, Jochen Felix Hienz, Brigitte Wiedmann, Michael Beck, Hermann Metzger, Philipp Mølhøj, Michael Knoblich, Constanze Grauschopf, Ulla Reusch, Dietmar Bulau, Patrick |
author_sort | Haberger, Markus |
collection | PubMed |
description | Modifications like asparagine deamidation, aspartate isomerization, methionine oxidation, and lysine glycation are typical degradations for recombinant antibodies. For the identification and functional evaluation of antibody critical quality attributes (CQAs) derived from chemical modifications in the complementary-determining regions (CDRs) and the conserved regions, an approach employing specific stress conditions, elevated temperatures, pH, oxidizing agents, and forced glycation with glucose incubation, was applied. The application of the specific stress conditions combined with ion exchange chromatography, proteolytic peptide mapping, quantitative liquid chromatography mass spectrometry, and functional evaluation by surface plasmon resonance analysis was adequate to identify and functionally assess chemical modification sites in the CDRs of a recombinant IgG1. LC-Met-4, LC-Asn-30/31, LC-Asn-92, HC-Met-100c, and HC Lys-33 were identified as potential CQAs. However, none of the assessed degradation products led to a complete loss of functionality if only one light or heavy chain of the native antibody was affected. |
format | Online Article Text |
id | pubmed-3984323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-39843232014-04-18 Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes Haberger, Markus Bomans, Katrin Diepold, Katharina Hook, Michaela Gassner, Jana Schlothauer, Tilman Zwick, Adrian Spick, Christian Kepert, Jochen Felix Hienz, Brigitte Wiedmann, Michael Beck, Hermann Metzger, Philipp Mølhøj, Michael Knoblich, Constanze Grauschopf, Ulla Reusch, Dietmar Bulau, Patrick MAbs Report Modifications like asparagine deamidation, aspartate isomerization, methionine oxidation, and lysine glycation are typical degradations for recombinant antibodies. For the identification and functional evaluation of antibody critical quality attributes (CQAs) derived from chemical modifications in the complementary-determining regions (CDRs) and the conserved regions, an approach employing specific stress conditions, elevated temperatures, pH, oxidizing agents, and forced glycation with glucose incubation, was applied. The application of the specific stress conditions combined with ion exchange chromatography, proteolytic peptide mapping, quantitative liquid chromatography mass spectrometry, and functional evaluation by surface plasmon resonance analysis was adequate to identify and functionally assess chemical modification sites in the CDRs of a recombinant IgG1. LC-Met-4, LC-Asn-30/31, LC-Asn-92, HC-Met-100c, and HC Lys-33 were identified as potential CQAs. However, none of the assessed degradation products led to a complete loss of functionality if only one light or heavy chain of the native antibody was affected. Landes Bioscience 2014-03-01 2014-01-17 /pmc/articles/PMC3984323/ /pubmed/24441081 http://dx.doi.org/10.4161/mabs.27876 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Report Haberger, Markus Bomans, Katrin Diepold, Katharina Hook, Michaela Gassner, Jana Schlothauer, Tilman Zwick, Adrian Spick, Christian Kepert, Jochen Felix Hienz, Brigitte Wiedmann, Michael Beck, Hermann Metzger, Philipp Mølhøj, Michael Knoblich, Constanze Grauschopf, Ulla Reusch, Dietmar Bulau, Patrick Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes |
title | Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes |
title_full | Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes |
title_fullStr | Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes |
title_full_unstemmed | Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes |
title_short | Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes |
title_sort | assessment of chemical modifications of sites in the cdrs of recombinant antibodies: susceptibility vs. functionality of critical quality attributes |
topic | Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984323/ https://www.ncbi.nlm.nih.gov/pubmed/24441081 http://dx.doi.org/10.4161/mabs.27876 |
work_keys_str_mv | AT habergermarkus assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT bomanskatrin assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT diepoldkatharina assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT hookmichaela assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT gassnerjana assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT schlothauertilman assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT zwickadrian assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT spickchristian assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT kepertjochenfelix assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT hienzbrigitte assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT wiedmannmichael assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT beckhermann assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT metzgerphilipp assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT mølhøjmichael assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT knoblichconstanze assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT grauschopfulla assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT reuschdietmar assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes AT bulaupatrick assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes |